Text Size
134 studies found for:    bone marrow biopsy OR bone marrow aspiration OR bone marrow exam | Open Studies | NIH, U.S. Fed

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Recruiting Eltrombopag for Moderate Aplastic Anemia
Conditions: Eltrombopag;   Aplastic Anemia;   Aplastic Anemia Treatment;   Moderate Aplastic Anemia;   Moderate Aplastic Anemia Treatment
Intervention: Drug: Eltrombopag
22 Recruiting Cause of Unexplained Anaphylaxis
Condition: Anaphylaxis
Intervention:
23 Recruiting Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers
Condition: Healthy
Intervention:
24 Recruiting Bone Marrow Stromal Cell Infusions for Stem Cell Transplant Complications
Condition: Graft-Versus-Host Disease
Intervention: Procedure: Bone Marrow Stromal Cell Infusion
25 Recruiting Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
Conditions: Multiple Myeloma;   Leukemia, Plasma Cell
Interventions: Drug: Carfilzomib;   Drug: Melphalan;   Drug: Filgrastim
26 Recruiting Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols
Condition: Central Nervous System Neoplasms
Intervention:
27 Recruiting Use of G-CSF to Obtain Blood Cell Precursors
Conditions: Chronic Granulomatous Disease;   Healthy;   Immunologic Disease;   Leukocyte Adhesion Deficiency Syndrome;   Severe Combined Immunodeficiency
Intervention:
28 Recruiting Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia
Conditions: Cutaneous T Cell Lymphoma;   Hodgkin's Disease;   Neoplasm;   Non Hodgkin's Lymphoma;   Peripheral T Cell Lymphoma
Interventions: Drug: Y-90 Humanized Anti-Tac;   Drug: Calcium-DTPA
29 Recruiting Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)
Conditions: Smoldering Myeloma;   Monoclonal Gammopathy of Undetermined Significance
Intervention:
30 Recruiting Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency
Condition: Severe Combined Immunodeficiency Syndrome
Intervention: Drug: CD34+ cells transduced with ADA retrovir
31 Recruiting Lenalidomide Maintenance Therapy for Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Lenalidomide
32 Not yet recruiting Phase II Study of Subcutaneous (SC) Bortezomib, Lenalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma; Followed by SC Bortezomib Maintenance
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib;   Drug: Lenalidomide;   Drug: Dexamethasone
33 Not yet recruiting MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: MLN9708;   Drug: Dexamethasone
34 Recruiting LMB-2 to Treat Hairy Cell Leukemia
Conditions: Positive Hairy Cell Leukemia;   CD25-Expressing Hairy Cell Leukemia
Intervention: Biological: LMB-2
35 Recruiting A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
Conditions: Anaphylaxis;   Hypotension;   Bronchospasm;   Angioedema
Interventions: Drug: Epinephrine;   Procedure: Bone Marrow Apsiration;   Drug: Omalizumab (Xolair)
36 Recruiting Natural Killer Cells and Bortezomib to Treat Cancer
Conditions: Lung or Prostatic Neoplasms;   Colorectal or Kidney Neoplasms;   Pancreatic Neoplasms;   Leukemia, Myelogenous, Chronic Lymphocytic Leukemia, BCR-ABL Positive;   Melanoma;   CLL
Intervention: Drug: NK cells +CliniMACs CD3 and CD56 systems
37 Recruiting EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection
Conditions: AIDS Related Lymphoma;   HIV Infection
Interventions: Biological: Rituximab;   Biological: filgrastim;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: vincristine sulfate
38 Recruiting Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
Condition: Systemic Capillary Leak Syndrome
Intervention:
39 Recruiting A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers
Condition: Monoclonal B-Cell Lymphocytosis
Intervention:
40 Recruiting Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
Conditions: Lymphoma;   Leukemia
Intervention:
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years